Sirona Biochem Corp Stock Performance
| SRBCF Stock | USD 0.06 0.00 0.00% |
The entity has a beta of -0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sirona Biochem are expected to decrease at a much lower rate. During the bear market, Sirona Biochem is likely to outperform the market. Sirona Biochem Corp right now has a risk of 7.28%. Please validate Sirona Biochem maximum drawdown and the relationship between the downside variance and day median price , to decide if Sirona Biochem will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sirona Biochem Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Sirona Biochem is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.5 M |
Sirona |
Sirona Biochem Relative Risk vs. Return Landscape
If you would invest 6.23 in Sirona Biochem Corp on September 4, 2024 and sell it today you would lose (0.66) from holding Sirona Biochem Corp or give up 10.59% of portfolio value over 90 days. Sirona Biochem Corp is currently producing 0.062% returns and takes up 7.2787% volatility of returns over 90 trading days. Put another way, 64% of traded pink sheets are less volatile than Sirona, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Sirona Biochem Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sirona Biochem's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Sirona Biochem Corp, and traders can use it to determine the average amount a Sirona Biochem's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0085
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | SRBCF |
| Negative Returns |
Estimated Market Risk
| 7.28 actual daily | 64 64% of assets are less volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sirona Biochem is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sirona Biochem by adding Sirona Biochem to a well-diversified portfolio.
Sirona Biochem Fundamentals Growth
Sirona Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sirona Biochem, and Sirona Biochem fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sirona Pink Sheet performance.
| Return On Equity | -35.56 | |||
| Return On Asset | -1.35 | |||
| Operating Margin | (4.92) % | |||
| Current Valuation | 24.5 M | |||
| Shares Outstanding | 251.73 M | |||
| Price To Earning | (7.33) X | |||
| Price To Book | 36.93 X | |||
| Price To Sales | 36.46 X | |||
| Revenue | 268.02 K | |||
| EBITDA | (2.3 M) | |||
| Cash And Equivalents | 1.13 M | |||
| Total Debt | 468.77 K | |||
| Debt To Equity | 0.60 % | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.16 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 1.29 M | |||
| Retained Earnings | (12.03 M) | |||
| Current Asset | 1.49 M | |||
| Current Liabilities | 801 K | |||
About Sirona Biochem Performance
By analyzing Sirona Biochem's fundamental ratios, stakeholders can gain valuable insights into Sirona Biochem's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sirona Biochem has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sirona Biochem has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Sirona Biochem is traded on OTC Exchange in the United States.Things to note about Sirona Biochem Corp performance evaluation
Checking the ongoing alerts about Sirona Biochem for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sirona Biochem Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sirona Biochem Corp had very high historical volatility over the last 90 days | |
| Sirona Biochem Corp has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 268.02 K. Net Loss for the year was (2.31 M) with profit before overhead, payroll, taxes, and interest of 199.25 K. | |
| Sirona Biochem Corp has accumulated about 1.13 M in cash with (2.16 M) of positive cash flow from operations. |
- Analyzing Sirona Biochem's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sirona Biochem's stock is overvalued or undervalued compared to its peers.
- Examining Sirona Biochem's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sirona Biochem's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sirona Biochem's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sirona Biochem's pink sheet. These opinions can provide insight into Sirona Biochem's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sirona Pink Sheet analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stocks Directory Find actively traded stocks across global markets |